Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.

The pharmacokinetics of trovafloxacin [CP-99,219; 7-(3-azabicyclo[3.1.0]hexyl)-naphthyridone] were studied in rats, dogs, and monkeys following oral and intravenous administration. After intravenous dosing, the systemic clearances of trovafloxacin in rats, dogs, and monkeys were 12.5, 11.1, and 7.2...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Teng, R, Girard, D, Gootz, T D, Foulds, G, Liston, T E
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1996
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163158/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8851571/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.3.561
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!